Determinants of Myelosuppression in the Treatment of Non-small Cell Lung Cancer with Cisplatin-containing Chemotherapy

Search this Article

Author(s)

    • MATSUI Kaoru
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • MASUDA Noriyuki
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • UCHIDA Yasuo
    • Scientific Affairs Department, Pharmaceuticals Group. Nippon Kayaku Co., Ltd.,
    • FUKUOKA Masahiro
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • NEGORO Shunichi
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • YANA Takashi
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • KUSUNOKI Yoko
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • KUDOH Shinzoh
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • KAWASE Ichiro
    • 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
    • KUBOTA Kaoru
    • Department of Internal Medicine, National Kinki Central Hospital

Journal

  • Japanese journal of cancer research : gann

    Japanese journal of cancer research : gann 87(7), 781-786, 1996-07-31

References:  19

Codes

  • NII Article ID (NAID)
    10008074652
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09105050
  • Data Source
    CJP 
Page Top